EUVIMEDEUVIMED entdecken
Open Access

A sequencing-based screening method identifies regulators of EGFR signaling from nonviable mutants in Caenorhabditis elegans

Hillel T Schwartz iD, Paul W Sternberg iD

Science Signaling · 2025

DOI: 10.1126/scisignal.adp9377 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Signaling, 2025. Verfasst von Hillel T Schwartz und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125, USA. Hauptthemen laut MEDLINE: Caenorhabditis elegans, Signal Transduction, ErbB Receptors, Caenorhabditis elegans Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Suppressor screens can identify genetic modifiers of biochemical pathways but generally require that the suppressed mutant be viable and fertile. We developed a screening method that obviated this requirement and enabled the identification of mutations that partially suppressed the early developmental arrest and lethality caused by loss of the epidermal growth factor (EGF) receptor ortholog LET-23 in Caenorhabditis elegans . We chemically mutagenized animals carrying the loss-of-function allele let-23 ( sy15 ), recovered let-23 ( sy15 ) homozygotes that escaped early developmental arrest but were nevertheless inviable, and sequenced their genomes. Testing of candidate causal mutations identified 11 genes that, when mutated, mitigated the early lethality caused by loss of EGF signaling. These included genes encoding homologs of the small guanosine triphosphatase (GTPase) Ras ( let-60 ), which is a downstream effector of LET-23, and of regulators of the small GTPase Rho, including the homolog of the phosphotyrosine-binding protein TENSIN ( tns-1 ). We also recovered suppressing mutations in genes encoding nuclear proteins that protect against DNA damage, including the homolog of MutS homolog 4 ( him-14 ). Genetic experiments were consistent with the repression of Rho activity or the activation of the DNA damage response compensating for the loss of EGF signaling. This sequencing-based, whole-animal screening method may be adapted to other organisms to enable the identification of mutations for which the phenotype does not allow the recovery of viable animals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Caenorhabditis elegansSignal TransductionErbB ReceptorsCaenorhabditis elegans ProteinsMutationAnimals

Substanzen

ErbB ReceptorsCaenorhabditis elegans Proteinslet-23 protein, C elegans

Autor:innen und Institutionen

  • Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125, USA.

ORCID-Profile: Hillel T Schwartz, Paul W Sternberg

Förderung

  • NIH HHS

Zitieren

APA

Schwartz, H. T., & Sternberg, P. W. (2025). A sequencing-based screening method identifies regulators of EGFR signaling from nonviable mutants in Caenorhabditis elegans. Science Signaling. https://doi.org/10.1126/scisignal.adp9377

Vancouver

Schwartz HT, Sternberg PW. A sequencing-based screening method identifies regulators of EGFR signaling from nonviable mutants in Caenorhabditis elegans. Science Signaling. 2025. doi:10.1126/scisignal.adp9377

BibTeX
@article{Schwartz2025,
  author = {Schwartz, Hillel T and Sternberg, Paul W},
  title = {A sequencing-based screening method identifies regulators of EGFR signaling from nonviable mutants in Caenorhabditis elegans},
  journal = {Science Signaling},
  year = {2025},
  doi = {10.1126/scisignal.adp9377}
}
Kostenlos starten →